Page 30 - MemoriaCIBER-2017ENG

Over 2017 CIBER-BBN has kept up an excellent lev- el of scienti c work, with an increase in the number of scienti c publications, recovering from the slight drop that had been seen in the last few years We go on maintaining high quality standards, with roughly 70% of our production in rst quartile journals and getting close to 30% in the rst decile
We have also seen an improvement in the indicators (press releases, number of appearances in the me- dia, presence in the social networks, etc ) connected with communication and the visibility of our work for society
The Management Committee has made an e ort with the assistance of a consultancy company in the preparation of a strategic plan for coming peri- od 2018-2021 This process has meant an in-depth re ection on the centre’s model which has involved a review of procedures and research initiatives, such as the traditional intramural projects, that now take on a more exible format New valorisation projects have been conceived, with additional nancing, to in- crease the TRL level of technologies and encourage their ISCIII Transfer New parameters based on sci- enti c quality and cooperation have also been set to annually evaluate the Groups and to accept changes of the principal investigator
Although the strategic plan meant an important milestone in 2017, I would also like to stress the commitment taken on to propose a project focus- sing on nanomedicine as a key technology for solv- ing the problems of ageing in European society for the call for new preparatory actions for new FET Flagships CIBER-BBN has piloted the ambitious NANO4P (Nanomedicine for People) project, which aims to generate knowledge and develop technol- ogies enabling increasing the average number of years with no illness
In the scope of Technology transfer, four projects co- nanced with businesspersons
have been taken on, representing a success as re- gards attracting private investment to our research
We have gone on drawing closer to clinical work and at the Sessions held in Santander there were two clinical forums of great interest for outreach to doc- tors and researchers
Because of the limitations existing to contracting and giving priority to researchers’ contracts, the always highly-valued launching grants for young research- ers could not be arranged this time We hope to be able to recover this initiative in the next few years
As regards NANBIOSIS, the MINECO has been re- quested for revalidation of the ICTS, the annual eval- uation period used as a basis for assigning economic incentives has been readjusted and the infrastruc- ture has continued to be publicised at national and international forums
As a result of the annual evaluation of the Research Groups for their work done in 2016 one group has been discontinued
In cooperation with other thematic areas we have closed a call for projects along with CIBERER and CI- BERES at which four projects were nanced 2017 was the rst year for the three new thematic areas This aspect means excellent cooperation opportuni- ties for our CIBER In fact, work has been done on a collaborative initiative with CIBERONC which we hope to extend to other areas in the future
The following pages will provide further information which I hope will be of interest to you There is no question that the work done by the CIBER-BBN in a year is hard to sum up in just a few pages, and I would like to take this opportunity to thank the whole BBN and CIBER community for the daily e orts made, at the same time as wishing to encourage them to go on working as we have up to now, with our sights set on continuing to progress along the path towards knowledge and excellence
With best regards,
Scienti c Director’s Presentation
Ramón Martínez Máñez
30 CIBER ANNUAL REPORT 2017